Victor Farutin

Victor is the senior director, computational biology at Verve. Prior to joining Verve, Victor worked at an early-stage diagnostic company and Momenta Pharmaceuticals (acquired by Johnson & Johnson in 2020), where the programs he and his team contributed to spanned across novel therapeutics, complex generics and biosimilars. The scope of these projects ranged from discovery research to assay optimization and regulatory communications with particular emphasis on high-throughput biology characterization (e.g., genetic variants, transcriptomics, proteomics, etc.) of pre-/clinical samples in the context of translational studies. Prior to that, Victor held positions of increasing responsibility at Pfizer Research Technology Center and Millennium Pharmaceuticals where he started his career in industry after obtaining Ph.D. in physics and mathematics/biophysics from Moscow Institute of Physics and Technology and completing postdoctoral training at the University of Michigan.